{"id":2789,"date":"2012-05-18T09:00:18","date_gmt":"2012-05-18T17:00:18","guid":{"rendered":"http:\/\/www.xbizx.com\/index.php\/2789\/human-genome-sciences-adopts-poison-pill-to-thwart-glaxo-takeover-new-york-times\/"},"modified":"2012-05-18T09:00:18","modified_gmt":"2012-05-18T17:00:18","slug":"human-genome-sciences-adopts-poison-pill-to-thwart-glaxo-takeover-new-york-times","status":"publish","type":"post","link":"https:\/\/www.xbizx.com\/index.php\/2789\/human-genome-sciences-adopts-poison-pill-to-thwart-glaxo-takeover-new-york-times\/","title":{"rendered":"Human Genome Sciences Adopts Poison Pill to Thwart Glaxo Takeover &#8211; New York Times"},"content":{"rendered":"<p><a target=\"_blank\" rel=\"nofollow\" href='http:\/\/dealbook.nytimes.com\/2012\/05\/17\/human-genome-sciences-adopts-poison-pill-to-thwart-glaxo-takeover\/'>Human Genome Sciences Adopts Poison Pill to Thwart Glaxo Takeover &#8211; New York Times<\/a><br \/>The biotechnology company Human Genome Sciences on Thursday adopted a shareholder rights plan, or poison pill, as it sought to fend off a $2.59 billion takeover offer from the drug maker GlaxoSmithKline. The news comes a week after Glaxo &#8230;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Human Genome Sciences Adopts Poison Pill to Thwart Glaxo Takeover &#8211; New York TimesThe biotechnology company Human Genome Sciences on Thursday adopted a shareholder rights plan, or poison pill, as it sought to fend off a $2.59 billion takeover offer from the drug maker GlaxoSmithKline. The news comes a week after Glaxo &#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2789","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/www.xbizx.com\/index.php\/wp-json\/wp\/v2\/posts\/2789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xbizx.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xbizx.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xbizx.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xbizx.com\/index.php\/wp-json\/wp\/v2\/comments?post=2789"}],"version-history":[{"count":0,"href":"https:\/\/www.xbizx.com\/index.php\/wp-json\/wp\/v2\/posts\/2789\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.xbizx.com\/index.php\/wp-json\/wp\/v2\/media?parent=2789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xbizx.com\/index.php\/wp-json\/wp\/v2\/categories?post=2789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xbizx.com\/index.php\/wp-json\/wp\/v2\/tags?post=2789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}